Natural Capsules Ltd.

View in App
335.00 -1.60 ▼-0.5%

30 November 2023, 01:10:00 PM
Volume: 15,571

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.naturalcapsules.com
Market Cap 313.19 Cr.
Enterprise Value(EV) 396.50 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 12.08 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 27.74 Trailing Twelve Months Ending 2023-09
Industry PE 38.14 Trailing Twelve Months Ending 2023-09
Book Value / Share 135.02 Trailing Twelve Months Ending 2023-09
Price to Book Value 2.48 Calculated using Price: 335.00
Dividend Yield 0.30 Period Ending 2023-03
No. of Shares Subscribed 0.93 Cr. 9,349,050 Shares
FaceValue 10
About Natural Capsules Ltd.
Natural Capsules is a public limited company established in the year 1993.The company is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.

Natural Capsules Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Natural Capsules Ltd. Performance

View details >>
1 Day
-0.48%
1 Week
-3.94%
1 Month
-9.23%
3 Month
-13.09%
6 Month
-10.55%
1 Year
-36.92%
2 Year
+68.55%
5 Year
+411.29%
10 Year
+1068.88%

Natural Capsules Ltd. Fundamental Ratios

View details >>
6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 2.05 3.50 1.54 11.74 19.18 17.89
Return on Capital Employed (%) 3.71 4.51 3.71 14.52 20.75 16.18
Return on Assets (%) 1.56 2.66 1.16 8.05 10.65 8.14

Natural Capsules Ltd. Balance Sheet

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 54 55 56 62 83 123 126
Non Curr. Liab. 2 1 1 2 37 74 68
Curr. Liab. 15 16 18 33 45 67 73
Minority Int. 25 75
Equity & Liab. 71 73 75 97 164 289 342
Non Curr. Assets 29 35 37 47 89 187 218
Curr. Assets 42 38 38 50 76 102 124
Misc. Exp. not W/O
Total Assets 71 73 75 97 164 289 342

Natural Capsules Ltd. Profit and Loss

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 55 60 62 80 135 172 158
Other Income 1 1 1 1 2 2 1
Total Income 56 61 63 80 137 174 159
Total Expenditure -49 -55 -56 -68 -111 -138 -131
PBIDT 6 6 6 12 27 36 28
Interest 0 -1 -1 -1 -2 -4 -5
Depreciation -4 -3 -4 -4 -5 -7 -8
Taxation -1 0 -1 -2 -5 -7 -4
Exceptional Items 0 2
PAT 1 2 1 7 14 18 11
Minority Interest
Share Associate
Other Related Items 0 0 0
Consolidated Net Profit 1 2 1 7 14 18 11
Adjusted EPS 1 3 1 9 20 20 12

Natural Capsules Ltd. Cash Flow

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 5 2 7 6 -1 17
Cash Fr. Inv. -1 -7 -6 -9 -46 -105
Cash Fr. Finan. -4 4 -1 3 48 87
Net Change 0 -1 0 0 1 0
Cash & Cash Eqvt 1 0 0 0 1 1

Natural Capsules Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 54.38 56.58 56.57 56.57 56.56 56.56 56.56 56.56 56.56
Public 45.62 43.42 43.43 43.43 43.44 43.44 43.44 43.44 43.44
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Natural Capsules Ltd. Announcements

View details >>
Fri, 24 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish toinform you that the Company participated in the Investors Conference Call on Tuesday 21 November 2023 enclosedherewith please find transcript of earnings conference call on Unaudited Financial Results for the Quarter and half yearended on 30 September 2023. No unpublished price sensitive information was shared/discussed in the meeting. Kindlytake the same on your record.
Tue, 21 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish toinform you that the Company participated in the Investors Conference Call today i.e. Tuesday 21st November 2023 onUnaudited financial results for the quarter and half year ended 30th September 2023.No unpublished price sensitive information was shared/discussed in the meeting.Audio of the conference call has been uploaded at the Companys website:http://www.naturalcapsules.com/pdf/Conference%20call-NATURAL%20CAPSULES%20LTD-21.11.2023.mp3Yours
Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 Please find enclosed herewith Investor Presentation in connection with unaudited standalone and consolidated financials for the quarter and half year ended 30.09.2023

Natural Capsules Ltd. Technical Scans

View details >>
Wed, 29 Nov 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Natural Capsules Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 288,124.14 1,212.40 +0.8%
Divi's Laboratories Ltd. 98,985.27 3,805.25 +2.0%
Cipla Ltd. 97,035.44 1,199.65 -0.2%
Dr. Reddy's Laboratories Ltd. 95,335.50 5,757.05 +0.7%
Apollo Hospitals Enterprise Ltd. 77,919.78 5,495.70 +1.4%
Mankind Pharma Ltd. 76,041.70 1,899.30 +0.0%
Torrent Pharmaceuticals Ltd. 70,779.09 2,119.00 +1.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 33.70 1,212.40 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-09 74.33 3,805.25 +2.0%
Cipla Ltd. Consolidated 2023-09 28.10 1,199.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.73 5,757.05 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 111.72 5,495.70 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 59.32 1,899.30 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.06 2,119.00 +1.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.82 1,212.40 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-09 7.81 3,805.25 +2.0%
Cipla Ltd. Consolidated 2023-09 3.91 1,199.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.74 5,757.05 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 11.99 5,495.70 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 9.02 1,899.30 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.55 2,119.00 +1.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,212.40 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,805.25 +2.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,199.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,757.05 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,495.70 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,899.30 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,119.00 +1.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,212.40 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,805.25 +2.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,199.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,757.05 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,495.70 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,899.30 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,119.00 +1.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,212.40 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,805.25 +2.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,199.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,757.05 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,495.70 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,899.30 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,119.00 +1.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,212.40 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,805.25 +2.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,199.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,757.05 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,495.70 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,899.30 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,119.00 +1.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,212.40 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,805.25 +2.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,199.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,757.05 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,495.70 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,899.30 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,119.00 +1.3%

Natural Capsules Ltd. FAQ's

What is Natural Capsules share price?
Can I buy Natural Capsules shares now?
What is the Dividend Yield of Natural Capsules?
What is the Market Cap of Natural Capsules?
What are the key metrics to analyse Natural Capsules?
What is the 52 Week High and Low of Natural Capsules?
What is the trend of Natural Capsules share price?